Predicting tuberculosis in hospitalized patients
Part of Infections clinical trials.
This study is creating a score to predict tuberculosis in hospitalized patients. By joining, you help doctors better identify who needs TB testing and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You are currently in the hospital and your doctor suspects you might have tuberculosis.
- You have had or will have a test on a breathing sample (such as sputum or fluid from your airways) to check for tuberculosis.
- You have not taken part in this study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks hospital workers and certain medical students to see how many have “latent TB,” meaning TB bacteria in the body that may not cause symptoms. The goal is to better understand who might need follow-up and prevention.
This trial helps doctors organize and “stage” tuberculosis (TB) using a structured approach. It may improve how care decisions are made by using confirmed TB information and donated samples/data.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study tests new, faster ways to detect tuberculosis (TB) using phlegm, tongue swabs, or urine. It aims to find a simpler and more accurate test than current ones, which could help you get the right treatment sooner.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.